Diageo: Guinness maker shares hit lowest level in four years amid China trade row January 5, 2024 Shares at Diageo are now trading at their lowest level since November 2020, in the face of weakening sales and trouble with Chinese trade.
Apple faces second downgrade, shares hit eight-week low January 5, 2024 Apple is grappling with a challenging start to the new year as concerns about iPhone sales lead to a second downgrade within just one week. Piper Sandler’s recent rating downgrade caused a substantial drop in Apple’s shares, hitting an eight-week low on Thursday. Harsh Kumar from Piper Sandler & Co. has downgraded his rating on [...]
Tesla ousted by China’s BYD as world’s top electric vehicle maker January 2, 2024 Tesla has been forced out of pole position by Chinese rival BYD as the world's most popular electric vehicle (EV) manufacturer.
Shift to smoke-free Britain continues as number of vape shops jumps again January 2, 2024 The number of independent vape shops has jumped again across the UK over the last year, amid plans to create a “smoke-free generation” by limiting their sale to children. Another 233 independent vape shops opened in 2023, a significant jump from 2022’s next increase of 61 and 2021’s net fall of 23, according to the [...]
A changing China: Looking ahead to commodities in 2024 December 31, 2023 Commodities face an uncertain 2024 as geopolitical and climate risks continue to grow
Copper prices end 2023 on a high as traders focus on supply constraints next year December 29, 2023 Copper saw a fourth-quarter rebound to close out 2023.
FTSE 100: London climbs to three-month high after Christmas break December 28, 2023 London’s top index moved 0.36 per cent , or 27.44 points higher, to finish at 7,724.95.
The five biggest global business meltdowns of the year December 28, 2023 City A.M. recaps the biggest global business nightmares of the year.
UK taxpayer faces £200m loss from bailout of Oneweb December 27, 2023 The UK taxpayer faces a £200m loss from the government's decision to bailout satellite-internet company Oneweb.
Astrazeneca to buy China’s Gracell Biotechnologies in $1.2bn deal December 27, 2023 Astrazeneca will buy Gracell Biotechnologies for up to $1.2bn as the Anglo-Swedish pharma company furthers its cell therapy ambitions and boosts its presence in China.